Sotera Health Company (SHC) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Broadview Heights, OH, United States. Der aktuelle CEO ist Michael Petras Jr..
SHC hat IPO-Datum 2020-11-20, 3,000 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $4.53B.
Sotera Health Company is a global provider of sterilization services and laboratory testing solutions for the medical device, pharmaceutical, and specialty product industries. The company operates across the United States, Canada, Europe, and internationally, offering gamma and electron beam irradiation, EO gas processing, and comprehensive microbiological and analytical chemistry testing through its Nelson Labs division. In addition to testing services, Sotera Health provides regulatory and technical advisory services to support medical device and biopharmaceutical manufacturers throughout their product development and commercialization. Founded in 2017 and headquartered in Broadview Heights, Ohio, the company serves a diverse customer base including medical device manufacturers, pharmaceutical companies, food and agricultural producers, and commercial advanced specialty application industries.